Managed Account Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$128K Buy
18,717
+5,943
+47% +$37.7K ﹤0.01% 2568
2015
Q1
$78K Buy
12,774
+9,121
+250% +$60.7K ﹤0.01% 2569
2014
Q4
$25K Buy
3,653
+1,531
+72% +$11.3K ﹤0.01% 2522
2014
Q3
$17K Buy
2,122
+931
+78% +$7.29K ﹤0.01% 2560
2014
Q2
$10K Buy
1,191
+255
+27% +$1.94K ﹤0.01% 2579
2014
Q1
$7K Buy
936
+629
+205% +$5.32K ﹤0.01% 2562
2013
Q4
$3K Buy
307
+202
+192% +$1.8K ﹤0.01% 2552
2013
Q3
$1K Buy
+105
New +$850 ﹤0.01% 2492

Other funds holding SPPI

Managed Account Advisors's SPPI Position: Q2 2015 in Review

Managed Account Advisors increased its Spectrum Pharmaceuticals Inc (SPPI) stake by 47% in Q2 2015, buying an estimated $37.7K and bringing the position to 18,717 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #2568.

Managed Account Advisors first reported a position in SPPI in Q3 2013 and has held it in 8 quarters since. 128 funds tracked by Wall St. Rank hold SPPI as of Q2 2015.

  • Managed Account Advisors held 18,717 shares of Spectrum Pharmaceuticals Inc worth $128K as of Q2 2015.
  • Managed Account Advisors bought 5,943 Spectrum Pharmaceuticals Inc shares in Q2 2015, an estimated $37.7K.
  • Spectrum Pharmaceuticals Inc made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2568 holding.
  • Managed Account Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q3 2013 and has held it in 8 quarters since.
  • 128 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.